Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Fish and Richardson
McKinsey
Accenture
QuintilesIMS
AstraZeneca
Dow
US Department of Justice
US Army

Generated: October 19, 2017

DrugPatentWatch Database Preview

ADVIL MIGRAINE LIQUI-GELS Drug Profile

« Back to Dashboard

What is the patent landscape for Advil Migraine Liqui-gels, and when can generic versions of Advil Migraine Liqui-gels launch?

Advil Migraine Liqui-gels is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in ADVIL MIGRAINE LIQUI-GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for Tradename: ADVIL MIGRAINE LIQUI-GELS

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list109
Clinical Trials: see list606
Patent Applications: see list9,377
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ADVIL MIGRAINE LIQUI-GELS at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
ADVIL MIGRAINE LIQUI-GELS
ibuprofen
CAPSULE;ORAL020402-002Mar 16, 2000OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Cerilliant
Queensland Health
Merck
Medtronic
Boehringer Ingelheim
Accenture
Healthtrust
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot